Finally, the fact that MCU is overexpressed in breast cancer patients and the clear evidence linking MCU to cancer invasion and growth, points to mitochondrial Ca2+ uptake as a potential therapeutic target in highly proliferative cancers. This evidence concerns the gene MCU and cancer.